抗体

Antibodies are present on the cell surface, leading to lysis and severe anemia.

血细胞表面存在某些特异的抗体，导致细胞溶解继而引起严重的贫血。

Thus the combination use of these two mAb may have a great potential value in clinic.

因此，联合应用这两种中和型单克隆抗体在MM的生物治疗中具有潜在的应用价值。

Indirect immunofluorescence was used to analyze the activity and specificity of the mAb.

用间接免疫荧光法对mAb的抗体活性及特异性进行测定。

OBJECTIVE: To evaluate the inhibition effects of bFGF mAb and cisplatin on melanoma B16 cell proliferation.

目的：探讨bFGF单克隆抗体联合顺铂对黑色素瘤B16细胞的抑制作用。

The chromosome of the positive hybridoma and the character of the mAb were analysed.

对所得阳性杂交瘤细胞作染色体分析并对单克隆抗体进行特性分析。

Objective: To study the propagation and phenotypes changes of killer cell CD3AK cell activated by CD3 mAb in vitro.

目的：研究肺癌清扫淋巴结的淋巴细胞，经CD3单克隆抗体激活后的杀伤细胞(CD3AK细胞)在体外的增殖和表型变化。

AIM: To investigate the effect of mycophenolic acid alone or in combination with anti B7-1 mAb on proliferation of T lymphocytes and the possible mechanisms.

目的： 探讨霉酚酸或与抗B7-1单克隆抗体联用对T细胞增殖的影响及其机制。

The combination of mAb and traditional chemotherapeutic drugs provides a more effective method in the treatment of cancer. The mechanism needs to be studied further.

抗体与化疗药物联合使用将为肿瘤治疗提供更为有效的方法，其机制有待进一步研究。

The results proved that the prepared mAb are qualified for application in clinic trial.

抗HFRS病毒单克隆抗体三批中试产品符合临床研究的质量要求。

Prospects :3-5 years. Mahler Qi and his team are preparing to increase the proportion of breast and ovarian cancer produce antibodies for human clinical trials.

前景：3-5年。马勒齐和他的小组正准备按比例增加乳腺癌和卵巢癌抗体的生产用于人类临床试验。

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。